NeOnc Technologies Holdings (NASDAQ: NTHI) remains an early-stage biotechnology company, but the recent Abu Dhabi IND authorization for NEO212 highlights a development strategy that has become ...

In February I wrote a post for Seeking Alpha on the gene therapy-focused biotech Intellia Therapeutics (NTLA), titled "2 Major Catalysts Will Determine Stock's Trajectory In 2026." At the time of ...

Seeking mental health help is a significant step, but that first intake session can often feel more like paperwork than progress, and a significant proportion of people 'drop out' or never return for ...

In Chiles v. Salazar, the Supreme Court of the United States (SCOTUS) recently held that a Colorado law banning conversion therapy, a discredited and harmful treatment for same-sex orientation and ...

Post-thrombotic syndrome is common after deep-vein thrombosis and can cause severe symptoms involving the limbs that impair patients’ activity and quality of life. Endovascular therapy can eliminate ...

Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The global epidemiology and ...

VESALIUS-CV is a large (N=12 257), rigorously conducted, international, randomized, placebo-controlled trial conducted in patients at high cardiovascular risk but without prior myocardial infarction ...

In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite prostaglandin E2 can block T cells—the killer cells of the immune system—in the ...

Workplace conversations rarely address childhood traumas or personal disappointments. Yet these formative experiences shape how people communicate, handle stress, and build trust–skills that are ...

Genfit SA ( (GNFT)) just unveiled an update. On November 10, 2025, GENFIT announced a research collaboration with EVerZom to advance exosome-based regenerative technology for treating Acute-On-Chronic ...